Bonnet AM - Search Results

1

Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.

Montel S, Bonnet AM, Bungener C. Montel S, et al. Among authors: bonnet am. J Geriatr Psychiatry Neurol. 2009 Jun;22(2):95-102. doi: 10.1177/0891988708328219. Epub 2009 Jan 15. J Geriatr Psychiatry Neurol. 2009. PMID: 19150974

2

Tactile hallucinations in Parkinson's disease.

Fénelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Fénelon G, et al. Among authors: bonnet am. J Neurol. 2002 Dec;249(12):1699-703. doi: 10.1007/s00415-002-0908-9. J Neurol. 2002. PMID: 12529792

3

[Non-motor symptoms in Parkinson's disease: cognition and behavior].

Bonnet AM, Czernecki V. Bonnet AM, et al. Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):295-304. doi: 10.1684/pnv.2013.0423. Geriatr Psychol Neuropsychiatr Vieil. 2013. PMID: 24026132 Review. French.

4

Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.

Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Among authors: bonnet am. Arch Neurol. 2003 May;60(5):690-4. doi: 10.1001/archneur.60.5.690. Arch Neurol. 2003. PMID: 12756132

5

Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y. Welter ML, et al. Among authors: bonnet am. Neurology. 2014 Apr 15;82(15):1352-61. doi: 10.1212/WNL.0000000000000315. Epub 2014 Mar 19. Neurology. 2014. PMID: 24647024 Free PMC article.

6

Back problems in Parkinson's disease: an underestimated problem.

Etchepare F, Rozenberg S, Mirault T, Bonnet AM, Lecorre C, Agid Y, Bourgeois P, Fautrel B. Etchepare F, et al. Among authors: bonnet am. Joint Bone Spine. 2006 May;73(3):298-302. doi: 10.1016/j.jbspin.2005.05.006. Epub 2005 Nov 15. Joint Bone Spine. 2006. PMID: 16376599

7

Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O; NS-Park CIC Network. Ory-Magne F, et al. Among authors: bonnet am. Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050. Epub 2013 Dec 26. Neurology. 2014. PMID: 24371304 Clinical Trial.

8

Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease.

Lücking CB, Chesneau V, Lohmann E, Verpillat P, Dulac C, Bonnet AM, Gasparini F, Agid Y, Dürr A, Brice A. Lücking CB, et al. Among authors: bonnet am. Arch Neurol. 2003 Sep;60(9):1253-6. doi: 10.1001/archneur.60.9.1253. Arch Neurol. 2003. PMID: 12975291

9

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C. Greffard S, et al. Among authors: bonnet am. Arch Neurol. 2006 Apr;63(4):584-8. doi: 10.1001/archneur.63.4.584. Arch Neurol. 2006. PMID: 16606773

10

Subthalamic stimulation in Parkinson disease: with or without anesthesia?

Maltête D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Maltête D, et al. Among authors: bonnet am. Arch Neurol. 2004 Mar;61(3):390-2. doi: 10.1001/archneur.61.3.390. Arch Neurol. 2004. PMID: 15023817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page